Literature DB >> 8445524

In vitro-in vivo correlation for modified-release formulations.

J Drewe1, P Guitard.   

Abstract

A correlation of in vitro dissolution rate measurements with in vivo pharmacokinetic results in a human study was obtained for a sustained-release formulation of bromocriptine. Different methods were applied to reach this correlation, and the various outcomes were compared.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8445524     DOI： 10.1002/jps.2600820204

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


  5 in total

Review 1.  The science of USP 1 and 2 dissolution: present challenges and future relevance.

Authors:  Vivian Gray; Gregg Kelly; Min Xia; Chris Butler; Saji Thomas; Stephen Mayock
Journal:  Pharm Res       Date:  2009-01-23       Impact factor: 4.200

2.  In vitro-in vivo relationship of oral extended-release dosage forms.

Authors:  F Y Liu; N C Sambol; R P Giannini; C Y Liu
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

3.  Statistical comparison of dissolution profiles to predict the bioequivalence of extended release formulations.

Authors:  J D Gomez-Mantilla; U F Schaefer; V G Casabo; T Lehr; C M Lehr
Journal:  AAPS J       Date:  2014-05-23       Impact factor: 4.009

4.  Estimation of agitation intensity in the GI tract in humans and dogs based on in vitro/in vivo correlation.

Authors:  N Katori; N Aoyagi; T Terao
Journal:  Pharm Res       Date:  1995-02       Impact factor: 4.200

5.  Development and evaluation of a novel biodegradable sustained release microsphere formulation of paclitaxel intended to treat breast cancer.

Authors:  Jacob Shiny; Thadkapally Ramchander; Puchchakayala Goverdhan; Mohammad Habibuddin; Jithan Venkata Aukunuru
Journal:  Int J Pharm Investig       Date:  2013-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.